Efficacy and safety of Solifenacin in the treatment of patients with urgency and urge incontinence WU / 中华泌尿外科杂志
Chinese Journal of Urology
; (12): 630-634, 2009.
Article
de Zh
| WPRIM
| ID: wpr-393150
Bibliothèque responsable:
WPRO
ABSTRACT
eiving Solifenacin 5.8% compared to those recei-ving Tolterodine 10.4%(P<0.05). Conclusion Solifenacin could be the safer and effective drug in the treatment of OAB patients with main complaints of urinary urgency and urgy incontinence.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Urology
Année:
2009
Type:
Article